Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is April 17, 2024.
All times in Eastern Daylight Time.
-
Aris Water Solutions, Inc. Schedules First Quarter 2024 Results Conference CallHOUSTON--(BUSINESS WIRE)--Aris Water Solutions, Inc. (NYSE: ARIS) (“Aris”, “Aris Water” or the “Company”) announced today that it will host a conference call to discuss its first quarter 2024 resul... more »
-
Celanese Corporation Declares Quarterly Dividend of $0.70 Per ShareDALLAS--(BUSINESS WIRE)--Celanese Corporation Declares Quarterly Dividends of $0.70 Per Share more »
-
Alcoa Corporation Reports First Quarter 2024 ResultsPITTSBURGH--(BUSINESS WIRE)--Alcoa Corp. reports 2024 first quarter results. more »
-
Moog Inc. to Announce Second Quarter Fiscal 2024 Earnings Webcast on April 26, 2024EAST AURORA, N.Y.--(BUSINESS WIRE)--Moog Inc. to Announce Second Quarter Fiscal 2024 Earnings Webcast on April 26, 2024 more »
-
JLR wählt Alkegen für fortschrittlichen Wärmeschutz seiner Batteriesysteme der nächsten GenerationIRVING, Texas--(BUSINESS WIRE)--Alkegen, ein Unternehmen für Hochleistungs-Spezialwerkstoffe, das innovative Lösungen für die Batterieindustrie entwickelt, gab heute bekannt, dass JLR die neue Prod... more »
-
DiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic StrokeMINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and cardio-ren... more »
-
LONDON--(BUSINESS WIRE)--Games Global Limited ("Games Global"), ein führender Entwickler, Vertreiber und Vermarkter von innovativen Online-Glücksspielinhalten im Casino-Stil und integrierten Busine... more »
-
LONDEN--(BUSINESS WIRE)--Games Global Limited (“Games Global”), een vooraanstaande ontwikkelaar, verdeler en marketeer van innovatieve online gaming-content in casinostijl en geïntegreerde business... more »
-
LONDRA--(BUSINESS WIRE)--Games Global Limited (“Games Global”), una delle principali società nello sviluppo, distribuzione e commercializzazione di innovative soluzioni business-to-business integra... more »
-
SAN FRANCISCO--(BUSINESS WIRE)--Affirm Holdings, Inc. (NASDAQ: AFRM), the payment network that empowers consumers and helps merchants drive growth, today announced that it will publish its third qu... more »
-
EL SEGUNDO, Calif.--(BUSINESS WIRE)--The Beachbody Company, Inc. (NYSE: BODi) (“BODi” or the “Company”), a leading health and fitness company, will release its first quarter 2024 results on Monday,... more »
-
HOUSTON--(BUSINESS WIRE)--KMI's board of directors today approved a cash dividend of $0.2875 per share for the first quarter ($1.15 annualized), payable on May 15, 2024. more »
-
Acadia Pharmaceuticals Presents New DAYBUE™ (trofinetide) Clinical Data at the 2024 American Academy of Neurology (AAN) Annual MeetingSAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that two oral presentations featuring DAYBUE™ (trofinetide) findings in Rett syndrome will be presented at the... more »
-
Chegg Reports New Hire Equity Grants Under NYSE Rule 303A.08SANTA CLARA, Calif.--(BUSINESS WIRE)--Chegg, Inc. (NYSE:CHGG), the leading student-first connected learning platform, today announced that on April 12, 2024, its Compensation Committee granted equi... more »
-
Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for “Extra-Strength” 40U Formulation of Jeuveau®NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that the Aesthe... more »